Shares in German chemicals and pharmaceuticals giant Bayer climbed Friday on a report it was nearing a $10 billion settlement with US plaintiffs claiming weedkiller Roundup caused their cancer.
Click here for original story, Bayer stock climbs on report of Roundup settlement
Source: Phys.org